Skip to main content
Top
Published in: Diabetologia 2/2011

01-02-2011 | Article

Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function

Authors: R. C. Loopstra-Masters, A. D. Liese, S. M. Haffner, L. E. Wagenknecht, A. J. Hanley

Published in: Diabetologia | Issue 2/2011

Login to get access

Abstract

Aims/hypothesis

Although protective relationships between coffee consumption and type 2 diabetes mellitus have consistently been observed, few studies have examined the relationships between coffee consumption and underlying pathophysiological defects that characterise diabetes aetiology. The aim of this study was to explore the associations between caffeinated and decaffeinated coffee consumption and measures of insulin sensitivity and secretion.

Methods

The study population included 954 multi-ethnic non-diabetic adults from the Insulin Resistance Atherosclerosis Study (IRAS). Multiple regression analyses were performed to examine the cross-sectional relationships between caffeinated and decaffeinated coffee intake and insulin sensitivity and acute insulin response, measured by a frequently sampled intravenous glucose tolerance test, 2 h postload glucose measured by OGTT, fasting insulin, and proinsulin to C-peptide ratios.

Results

Caffeinated coffee intake was positively associated with insulin sensitivity (β = 0.054; SE = 0.026; p = 0.04) and inversely related to 2 h postload glucose (β = −0.37; SE = 0.10; p = 0.0003) in fully adjusted models. Caffeinated coffee intake was not associated with acute insulin response or proinsulin ratios. Decaffeinated coffee intake was inversely related to 2 h postload glucose (β = −0.47; SE = 0.18; p = 0.0096) and positively related to acute insulin response (β = 0.191; SE = 0.077; p = 0.0132). Decaffeinated coffee intake was inversely related to the ratios of both intact and split proinsulin to C-peptide (β = −0.150; SE = 0.061; p = 0.0148; β = −0.254; SE = 0.068; p = 0.0002, respectively).

Conclusions/interpretation

In this cross-sectional study, caffeinated coffee was positively related to insulin sensitivity and decaffeinated coffee was favourably related to measures of beta cell function. These results provide pathophysiological insight as to how coffee could impact the risk of type 2 diabetes mellitus.
Literature
1.
go back to reference Huxley R, Lee CM, Barzi F et al (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 169:2053–2063CrossRefPubMed Huxley R, Lee CM, Barzi F et al (2009) Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 169:2053–2063CrossRefPubMed
2.
go back to reference Agardh EE, Carlsson S, Ahlbom A et al (2004) Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 255:645–652CrossRefPubMed Agardh EE, Carlsson S, Ahlbom A et al (2004) Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 255:645–652CrossRefPubMed
3.
go back to reference Arnlov J, Vessby B, Riserus U (2004) Coffee consumption and insulin sensitivity. JAMA 291:1199–1201CrossRefPubMed Arnlov J, Vessby B, Riserus U (2004) Coffee consumption and insulin sensitivity. JAMA 291:1199–1201CrossRefPubMed
4.
go back to reference van Dam RM, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ (2004) Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia 47:2152–2159CrossRefPubMed van Dam RM, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ (2004) Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia 47:2152–2159CrossRefPubMed
5.
go back to reference Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The Insulin Resistance Atherosclerosis Study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 5:464–472CrossRefPubMed Wagenknecht LE, Mayer EJ, Rewers M et al (1995) The Insulin Resistance Atherosclerosis Study (IRAS) objectives, design, and recruitment results. Ann Epidemiol 5:464–472CrossRefPubMed
6.
go back to reference Mayer-Davis EJ, D'Agostino R Jr, Karter AJ et al (1998) Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA 279:669–674CrossRefPubMed Mayer-Davis EJ, D'Agostino R Jr, Karter AJ et al (1998) Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study. JAMA 279:669–674CrossRefPubMed
7.
go back to reference Mayer-Davis EJ, Vitolins MZ, Carmichael SL et al (1999) Validity and reproducibility of a food frequency interview in a Multi-Cultural Epidemiology Study. Ann Epidemiol 9:314–324CrossRefPubMed Mayer-Davis EJ, Vitolins MZ, Carmichael SL et al (1999) Validity and reproducibility of a food frequency interview in a Multi-Cultural Epidemiology Study. Ann Epidemiol 9:314–324CrossRefPubMed
8.
go back to reference Liese AD, Schulz M, Moore CG, Mayer-Davis EJ (2004) Dietary patterns, insulin sensitivity and adiposity in the multi-ethnic Insulin Resistance Atherosclerosis Study population. Br J Nutr 92:973–984CrossRefPubMed Liese AD, Schulz M, Moore CG, Mayer-Davis EJ (2004) Dietary patterns, insulin sensitivity and adiposity in the multi-ethnic Insulin Resistance Atherosclerosis Study population. Br J Nutr 92:973–984CrossRefPubMed
9.
go back to reference Festa A, Williams K, Hanley AJ, Haffner SM (2008) Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 57:1638–1644CrossRefPubMed Festa A, Williams K, Hanley AJ, Haffner SM (2008) Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 57:1638–1644CrossRefPubMed
10.
go back to reference Dekker MJ, Gusba JE, Robinson LE, Graham TE (2007) Glucose homeostasis remains altered by acute caffeine ingestion following 2 weeks of daily caffeine consumption in previously non-caffeine-consuming males. Br J Nutr 98:556–562CrossRefPubMed Dekker MJ, Gusba JE, Robinson LE, Graham TE (2007) Glucose homeostasis remains altered by acute caffeine ingestion following 2 weeks of daily caffeine consumption in previously non-caffeine-consuming males. Br J Nutr 98:556–562CrossRefPubMed
11.
go back to reference Moisey LL, Kacker S, Bickerton AC, Robinson LE, Graham TE (2008) Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr 87:1254–1261PubMed Moisey LL, Kacker S, Bickerton AC, Robinson LE, Graham TE (2008) Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr 87:1254–1261PubMed
12.
go back to reference Moisey LL, Robinson LE, Graham TE (2010) Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males. Br J Nutr 103:833–841CrossRefPubMed Moisey LL, Robinson LE, Graham TE (2010) Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males. Br J Nutr 103:833–841CrossRefPubMed
13.
go back to reference Tunnicliffe JM, Shearer J (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 33:1290–1300CrossRefPubMed Tunnicliffe JM, Shearer J (2008) Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 33:1290–1300CrossRefPubMed
14.
go back to reference Wu T, Willett WC, Hankinson SE, Giovannucci E (2005) Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diab Care 28:1390–1396CrossRef Wu T, Willett WC, Hankinson SE, Giovannucci E (2005) Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diab Care 28:1390–1396CrossRef
15.
go back to reference van Dam RM (2008) Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab 33:1269–1283CrossRefPubMed van Dam RM (2008) Coffee consumption and risk of type 2 diabetes, cardiovascular diseases, and cancer. Appl Physiol Nutr Metab 33:1269–1283CrossRefPubMed
16.
go back to reference Fuhrman BJ, Smit E, Crespo CJ, Garcia-Palmieri MR (2009) Coffee intake and risk of incident diabetes in Puerto Rican men: results from the Puerto Rico Heart Health Program. Public Health Nutr 12:842–848CrossRefPubMed Fuhrman BJ, Smit E, Crespo CJ, Garcia-Palmieri MR (2009) Coffee intake and risk of incident diabetes in Puerto Rican men: results from the Puerto Rico Heart Health Program. Public Health Nutr 12:842–848CrossRefPubMed
17.
go back to reference Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J (2006) Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Int J Obes (Lond) 30:1742–1749CrossRef Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J (2006) Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Int J Obes (Lond) 30:1742–1749CrossRef
18.
go back to reference Sartorelli DS, Fagherazzi G, Balkau B et al (2010) Differential effects of coffee on the risk of type 2 diabetes according to meal consumption in a French cohort of women: the E3N/EPIC cohort study. Am J Clin Nutr 91:1002–1012CrossRefPubMed Sartorelli DS, Fagherazzi G, Balkau B et al (2010) Differential effects of coffee on the risk of type 2 diabetes according to meal consumption in a French cohort of women: the E3N/EPIC cohort study. Am J Clin Nutr 91:1002–1012CrossRefPubMed
19.
go back to reference Carlsson S, Hammar N, Grill V, Kaprio J (2004) Coffee consumption and risk of type 2 diabetes in Finnish twins. Int J Epidemiol 33:616–617CrossRefPubMed Carlsson S, Hammar N, Grill V, Kaprio J (2004) Coffee consumption and risk of type 2 diabetes in Finnish twins. Int J Epidemiol 33:616–617CrossRefPubMed
20.
go back to reference Odegaard AO, Pereira MA, Koh WP, Arakawa K, Lee HP, Yu MC (2008) Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 88:979–985PubMed Odegaard AO, Pereira MA, Koh WP, Arakawa K, Lee HP, Yu MC (2008) Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr 88:979–985PubMed
21.
go back to reference Paynter NP, Yeh HC, Voutilainen S et al (2006) Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am J Epidemiol 164:1075–1084CrossRefPubMed Paynter NP, Yeh HC, Voutilainen S et al (2006) Coffee and sweetened beverage consumption and the risk of type 2 diabetes mellitus: the atherosclerosis risk in communities study. Am J Epidemiol 164:1075–1084CrossRefPubMed
22.
go back to reference Salazar-Martinez E, Willett WC, Ascherio A et al (2004) Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140:1–8PubMed Salazar-Martinez E, Willett WC, Ascherio A et al (2004) Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140:1–8PubMed
23.
go back to reference Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P (2004) Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291:1213–1219CrossRefPubMed Tuomilehto J, Hu G, Bidel S, Lindstrom J, Jousilahti P (2004) Coffee consumption and risk of type 2 diabetes mellitus among middle-aged Finnish men and women. JAMA 291:1213–1219CrossRefPubMed
24.
go back to reference van Dam RM, Feskens EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360:1477–1478CrossRefPubMed van Dam RM, Feskens EJ (2002) Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360:1477–1478CrossRefPubMed
Metadata
Title
Associations between the intake of caffeinated and decaffeinated coffee and measures of insulin sensitivity and beta cell function
Authors
R. C. Loopstra-Masters
A. D. Liese
S. M. Haffner
L. E. Wagenknecht
A. J. Hanley
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1957-8

Other articles of this Issue 2/2011

Diabetologia 2/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine